drugset / Trial / NCT01018615
Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
Phase 1
Completed
28 enrolled
University of North Carolina, Chapel Hill
National Center for Complementary and Integrative Health (NCCIH) · collabNational Institutes of Health (NIH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if the safety, metabolism, and antioxidant activity of silymarin and green tea extract are changed when they are given in combination to patients with chronic hepatitis C infection.
Timeline
- Start
- 2009-11
- Primary completion
- 2013-04
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Silymarin | Traditional medicine (herbal / TCM) | 700 mg | Oral |